RECURSION PHARMACEUTICALS, INC. - CL A (RXRX)

Historical Portfolio Holders from Q1 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / CL A
Shares, excl. options Q3 2024
261M
Holdings value Q3 2024
$1.72B
Value change Q3 2024
+$28.7M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
259
Number of buys Q3 2024
147
Number of sells Q3 2024
-96
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 261M $1.72B +$28.7M $6.59 261
2024 Q2 252M $1.89B +$323M $7.50 265
2024 Q1 209M $2.09B +$31.1M $9.97 241
2023 Q4 206M $2.04B +$340M $9.86 194
2023 Q3 149M $1.14B +$163M $7.65 188
2023 Q2 128M $953M +$12.8M $7.47 154
2023 Q1 126M $841M +$14.6M $6.67 156
2022 Q4 124M $954M +$135M $7.71 142
2022 Q3 114M $1.21B +$75.7M $10.64 139
2022 Q2 106M $861M +$96.5M $8.14 129
2022 Q1 95M $680M -$13.2M $7.16 123
2021 Q4 94.3M $1.62B +$296M $17.13 122
2021 Q3 54.9M $1.26B +$182M $23.01 84
2021 Q2 47M $1.71B +$1.71B $36.50 77
2021 Q1 30 $1K $0 $33.33 1
2020 Q4 30 $1K $0 $33.33 1
2020 Q3 30 $1K $0 $33.33 1
2020 Q2 30 $1K $0 $33.33 1
2020 Q1 30 $1K $0 $33.33 1
2019 Q4 30 $1K $0 $33.33 1
2019 Q3 30 $1K $0 $33.33 1
2019 Q2 30 $1K $0 $33.33 1
2019 Q1 30 $1K $0 $33.33 1